Health-related quality of life in senior adults with epilepsy: what we know from randomized clinical trials and suggestions for future research (Q35617844)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 2003

Language	Label	Description	Also known as
English	Health-related quality of life in senior adults with epilepsy: what we know from randomized clinical trials and suggestions for future research	scientific article published on December 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

Europe PubMed Central

Health-related quality of life in senior adults with epilepsy: what we know from randomized clinical trials and suggestions for future research (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

object named as

Laura Vogtle

2

0 references

Frank G. Gilliam

3

object named as

Frank Gilliam

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

author name string

Roy Martin

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Edward Faught

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Epilepsy Behavior

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

626-634

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Prevalence of epilepsy in Rochester, Minnesota: 1940-1980.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

What We Owe Our Seniors with Epilepsy-Thoughts on Quality of Life

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Trials in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Pharmacologic management of epilepsy in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Epidemiology and drug treatment of epilepsy in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Anticonvulsant therapy in the elderly—A need for placebo controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Epilepsy in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Epilepsy in the elderly: some clinical and pharmacotherapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Epilepsy in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Choice and use of newer anticonvulsant drugs in older patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Quality-of-life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Folic Acid in Folate-deficient Patients with Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Stress and epilepsy: the value of a benzodiazepine--lorazepam

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Results of a nationwide Veterans Administration Cooperative Study comparing the efficacy and toxicity of carbamazepine, phenobarbital, phenytoin, and primidone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Differences in side effects between a conventional carbamazepine preparation and a slow-release preparation of carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Psychosocial outcomes of antiepileptic drug discontinuation. The Medical Research Council Antiepileptic Drug Withdrawal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Outcomes of add-on treatment with lamotrigine in partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Effects of vigabatrin on partial seizures and cognitive function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Influence of vigabatrin on cognitive performances and behaviour in patients with drug-resistant epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Effects of tiagabine monotherapy on abilities, adjustment, and mood

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Cognitive effects of anticonvulsant monotherapy in elderly patients: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Cognitive abilities and adjustment with gabapentin: results of a multisite study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. The Canadian Vigabatrin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Gabapentin versus vigabatrin as first add-on for patients with partial seizures that failed to respond to monotherapy: a randomized, double-blind, dose titration study. GREAT Study Investigators Group. Gabapentin in Refractory Epilepsy Add-on Treatm

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Quantitative assessment of seizure severity for clinical trials: a review of approaches to seizure components

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Lamotrigine Monotherapy Improves Depressive Symptoms in Epilepsy: A Double-Blind Comparison with Valproate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

The tolerability of lamotrigine in elderly patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Dose-response effect of levetiracetam 1000 and 2000 mg/day in partial epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Occurrence of psychosis in patients with epilepsy randomized to tiagabine or placebo treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

A research and service oriented multilevel assessment instrument

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

The measurement of life satisfaction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Measuring and monitoring general health status in elderly persons: practical and methodological issues in using the SF-36 Health Survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Measuring the health of seniors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Quality of life for people with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

The initial development of a health-related quality of life model as an outcome measure in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Commission on Outcome Measurement in Epilepsy, 1994-1997: final report

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

Manipulation of Cerebral Monoamines in the Treatment of Human Epilepsy: A Pilot Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2003.08.028

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YEBEH.2003.08.028

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35617844&oldid=2049234925"